Viewing StudyNCT00217386

Bugs

eRecord

Ignite Creation Date: 2024-05-05 @ 12:00 PM

Last Modification Date: 2024-10-26 @ 9:19 AM

Study NCT ID: NCT00217386

Status: COMPLETED

Last Update Posted: 2010-09-15

First Post: 2005-09-20

Brief Title: Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes

Sponsor: Fred Hutchinson Cancer Center

Organization: Fred Hutchinson Cancer Center

Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions:

Name

MyelodysplasticMyeloproliferative Diseases
Leukemia
Myelodysplastic Syndromes

Keywords:

Name	View

atypical chronic myeloid leukemia	View
de novo myelodysplastic syndromes	View
previously treated myelodysplastic syndromes	View
secondary myelodysplastic syndromes	View
myelodysplasticmyeloproliferative disease unclassifiable	View